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Developmental boundaryThe Notch pathway is crucial for a wide variety of developmental processes including the formation of tissue
boundaries. That it may function in calvarial suture development and ﬁgure in the pathophysiology of
craniosynostosis was suggested by the demonstration that heterozygous loss of function of JAGGED1 in
humans can cause Alagille syndrome, which has craniosynostosis as a feature. We used conditional gene
targeting to examine the role of Jagged1 in the development of the skull vault. We demonstrate that Jagged1
is expressed in a layer of mesoderm-derived sutural cells that lie along the osteogenic–non-osteogenic
boundary. We show that inactivation of Jagged1 in the mesodermal compartment of the coronal suture, but
not in the neural crest compartment, results in craniosynostosis. Mesodermal inactivation of Jagged1 also
results in changes in the identity of sutural cells prior to overt osteogenic differentiation, as well as defects in
the boundary between osteogenic and non-osteogenic compartments at the coronal suture. These changes,
surprisingly, are associated with increased expression of Notch2 and the Notch effector, Hes1, in the sutural
mesenchyme. They are also associated with an increase in nuclear β-catenin. In Twist1 mutants, Jagged1
expression in the suture is reduced substantially, suggesting an epistatic relationship between Twist1 and
Jagged1. Consistent with such a relationship, Twist1-Jagged1 double heterozygotes exhibit a substantial
increase in the severity of craniosynostosis over individual heterozygotes. Our results thus suggest that
Jagged1 is an effector of Twist1 in coronal suture development.l rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Establishing and maintaining tissue boundaries is essential for
morphogenesis and patterning (Dahmann and Basler, 1999; Irvine
and Rauskolb, 2001; Tepass et al., 2002). Boundaries not only provide
physical separation between tissues, but also function as signaling
interfaces, inﬂuencing the behavior of cells at the boundary and in
ﬂanking tissues. In developmental systems as diverse as the
Drosophila wing disc (Bray, 1998; Buceta et al, 2007; Major and
Irvine, 2005) and the mammalian hindbrain (Kiecker and Lumsden,
2005), loss of boundary integrity results in abnormal development.
Our recent work implicates a boundary between osteogenic and non-
osteogenic compartments in the development of the skull vault and in
the pathological condition of craniosynostosis, the premature fusion
of the calvarial bones (Merrill et al., 2006; Ting et al., 2009).
The skull vault consists of the paired frontal and parietal bones and
the single interparietal bone. The frontal bones are derived from
neural crest, the parietal bones from mesoderm (Chai and Maxson,
2006; Jiang et al., 2002). The interparietal bone is a composite, its
medial portion originating from neural crest and its lateral portionfrom mesoderm. Interposed between the bones of the skull vault are
sutures, ﬁbrous joints that maintain attachments between the bones
while accommodating the growth of the brain and providing
ﬂexibility to the overall head structure (Opperman, 2000; Rice,
2008; Slater et al., 2008).
Craniosynostosis is a common birth defect (1/2500 live births)
resulting in abnormalities in skull shape and, in some instances, in
neurological deﬁciencies (Wilkie, 1997). In humans, it is caused by
mutations in a number of genes (Cohen, 2006; Morriss-Kay and
Wilkie, 2005), including FGFRs 1-3 (Hajihosseini, 2008),MSX2 (Jabs et
al., 1993), TWIST1 (Howard et al., 1997), FIBRILLIN-1 (FBN1) (Sood et
al., 1996), TGFBR1, TGFBR2 (Loeys et al., 2005), EPHRINA4 (EFNA4)
(Merrill et al., 2006), EFNB1 (Twigg et al., 2004), RAB23 (Jenkins et al.,
2007), and the Notch ligand, JAGGED1 (Kamath et al., 2002). Studies in
mice have implicated, in addition, EphA4 (Ting et al., 2009), Axin2, (Yu
et al., 2005), Dusp6 (Li et al., 2007), Gdf6 (Settle et al., 2003), Pdgfr
alpha (Moenning et al., 2009) and Nell1 (Zhang et al., 2002). These
genes are components of several signaling pathways: Tgfbr1, Msx2,
and Gdf6 function in the Bmp pathway, Jagged1 in the Notch pathway,
EphrinA4, EphrinB1, EphA4, Dusp6, Pdgfr alpha, and Fgfr1-3 in the RTK
pathway. RAB23 is a component of the Hedgehog pathway, and Axin2
of the Wnt pathway. Twist1 functions to coordinate the activities of
the Bmp and RTK pathways (Connerney et al., 2008; Rice et al., 2000;
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cause craniosynostosis, potentially implicating a wide range of
processes in its pathophysiology.
The mechanisms underlying craniosynostosis are still largely
unknown (Boyadjiev, 2007). We investigated the developmental
basis of Saethre–Chotzen syndrome, caused by heterozygous loss of
function of Twist1 (Merrill et al., 2006; Ting et al., 2009). Wemade use
of Twist1+/− mutant mice, which exhibit a suture fusion phenotype
that resembles that seen in humans (Carver et al., 2002; el Ghouzzi et
al., 1997). We showed that Twist1 mutants have a defect in the
boundary between neural crest and mesoderm in the coronal suture
(Merrill et al., 2006). This boundary coincides with the boundary
between osteogenic and non-osteogenic compartments within the
suture. We showed further that ephrin-Eph signaling, controlled by
Twist1, has a role in the maintenance of this boundary: Reduced
dosage of Twist1 and EphA4 results in inappropriate targeting of
migratory osteogenic cells to the coronal suture (Ting et al., 2009).
This pathﬁnding defect, we proposed, is a key cause of craniosynos-
tosis in Twist1 and EphA4 mutants. We noted that the synostosis
phenotype caused by loss of EphA4 function is less severe than that of
Twist1+/− mutants, leading us to postulate that there are additional
genes downstream of Twist1 functioning in the maintenance of the
osteogenic–non-osteogenic boundary and in the pathophysiology of
craniosynostosis. Here we provide evidence that the Notch ligand,
Jagged1 is such a gene.
Constituents of the Notch pathway in vertebrates include the
membrane receptors, Notch1-3, and membrane bound ligands,
Jagged1, Jagged2 and Dll1, Dll3 and Dll4 (Kopan and Ilagan, 2009).
After ligand activation, the intracellular domain (NICD) of Notch
receptor is released by proteolysis and translocated to the nucleus.
Within the nucleus, NICD replaces repressors from the DNA binding
protein, CSL, and recruits a coactivator to form a transcription complex
that modulates the expression of downstream genes such as Hes and
Hey family genes (Bray, 2006). Notch signaling is critical for a variety of
developmental processes, including developmental boundary forma-
tion and cell type speciﬁcation (Bolós et al., 2007; Lai, 2004).
In humans, heterozygous loss of function of the Notch ligand,
JAGGED1, results in Alagille syndrome, a multi-organ disorder
characterized by impaired development of intrahepatic bile ducts, as
well as defects in the heart, eye, kidney, face, and skull (Alagille et al.,
1987; Emerick et al., 1999; Kamath et al., 2004; Krantz et al., 1998;
Oda et al., 1997). Synostosis of the coronal suture occurs at low
frequency (Kamath et al., 2002). Mutations in NOTCH2, a receptor for
JAGGED1, also cause many of the defects of Alagille syndrome, though
craniosynostosis has not been reported to be among them (McDaniell
et al, 2006).
In contrast to humans with JAGGED1 mutations, Jagged1+/− mice
develop largely normally. However, homozygous mutants die at E10.5
with vascular defects (Xue et al., 1999). Jagged1/Notch2 compound
mutants exhibit a set of deﬁciencies similar to those of humans
affected with Alagille syndrome, although these mutants do not have
craniosynostosis or other craniofacial defects (McCright et al., 2002).
Recently, conditional Jagged1 alleles were created, and several studies
have documented conditional phenotypes in different tissues,
including the inner ear (Brooker et al., 2006; Kiernan et al., 2006),
the anterior chamber of the eye (Le et al., 2009), and ducts of the
pancreas (Golson et al., 2009a). The consequences of inactivation of
Jagged1 in tissues of the skull vault have not yet been investigated.
That elements of the Notch pathway have roles in Alagille
syndrome, as well in developmental boundary formation, prompted
us to examine the role of Jagged1 in the development of the skull vault.
We demonstrate here that Jagged1 is expressed in a layer of
mesoderm-derived sutural cells that lie along the osteogenic–non-
osteogenic boundary between the frontal and parietal bones. We
show that conditional inactivation of Jagged1 in the mesodermal
compartment of the coronal suture results in craniosynostosis.Jagged1 expression in the coronal suture is reduced substantially in
Twist1+/− mutants, suggesting an epistatic relationship between
Twist1 and Jagged1. Consistent with such a relationship, Twist1+/−;
Jagged1+/− double mutants exhibit a substantial increase in the
severity of craniosynostosis over individual mutants, as well as an
expansion of Notch signaling activity prior to the appearance of
synostosis. We conclude that Jagged1 is an effector of Twist1 in coronal
suture development.
Materials and methods
Mouse mutants and genotyping
All geneticallymodiﬁedmice used in this study, as well asmethods
for determining their genotypes, were as described previously:
Jagged1 (Xue et al., 1999.), Twist1 (Chen and Behringer, 1995),
Jagged1 ﬂox (Brooker et al., 2006.), Wnt1-Cre (Danielian et al., 1998),
Mesp1-Cre (Saga et al., 1999), Dermo1-Cre (Yu et al., 2003) and R26R
(Soriano, 1999).
Skull preparation
The heads of postnatal day 21 mice were skinned and stained with
Alizarin Red S (80 mg/l in 1% KOH) to reveal mineralized bone. The
skulls were then cleared and stored in 100% glycerol.
Histochemical staining for alkaline phosphatase (ALP) and
β–galactosidase activity
The ALP staining procedures for whole-mount and tissue sections
were performed as described previously (Ishii et al., 2003), with
minor modiﬁcations. Brieﬂy, E14.5 embryo heads were ﬁxed in 70%
EtOH for 2 days and bisected sagittally for whole-mount staining.
Brains and skins were removed for clear illustration. The specimens
were then stained with 0.01% BCIP and 0.025% NBT in NTMT solution.
Cre-activated β–galactosidase activity in Mesp1-Cre;R26R, Mesp1-Cre;
R26R;Jagged1cko/cko, Dermo1-Cre;R262, Wnt1-Cre;R26R embryos were
detected by X-gal staining on 10-μm cryostat sections as described
previously (Ishii et al., 2003). Cryostat sections of E14.5 embryos
derived from a cross between Wnt1-Cre;Twist1+/−;Jagged1+/− males
and R26R females were stained with X-gal followed by immunostain-
ing for Jagged1 as described below.
Immunostaining and in situ hybridization
The heads of E12.5, E13.5 and E14.5 embryos were ﬁxed with 4%
paraformaldehyde and embedded in HistoPrep (Fisher Scientiﬁc).
Transverse frozen sections were cut in a cryostat at 10-μm thickness
(or 6-μm for β-catenin antibody staining). Immunoperoxidase
staining was performed by using streptavidin–biotin–peroxidase
method (Histostain-SP Kit, Zymed), followed by diaminobenzidin
tetrahydrochloride (DAB) substrate (Zymed) with or without hema-
toxylin counterstain according to the manufacturer's instructions.
Primary antibodies were purchased from the following companies
and used at the indicated dilutions: goat anti-Jagged1 (Santa Cruz, sc-
6011, 1:800), rabbit anti-Notch2 (sc-5545, 1:500), goat anti-Dll1 (sc-
12531, 1:500), goat anti-Hes1 (sc-13842, 1:500), rabbit anti-P-
Smad1/5/8 antibody (Cell Signaling, #9511, 1:100), rabbit anti-β-
catenin (Sigma, C2206, 1:500) and rabbit anti-P-Erk1/2 antibody (Cell
Signaling, #4376, 1:400). Indirect immunoﬂuorescence staining was
performed by using Rhodamin Red-X goat anti-rabbit IgG secondary
antibody (Invitrogen, R6394, 1:100). The cell nuclei were revealed by
co-staining with DAPI. Section in situ hybridization was carried out as
described previously (Chen et al., 2007). Digoxigenin-labeled Twist1
antisense RNA probe was generated as reported by Ishii et al. (Ishii et
al., 2003).
Fig. 1. Jagged1 is expressed in the prospective coronal suture. (A) We used an antibody against Jagged1 to stain transverse sections (as depicted) of E14.5 embryos. An adjacent
section was stained for the early osteoblast marker, alkaline phosphatase (ALP) with nuclear fast red counterstain. A superimposition of the Jagged1 immunostaining and ALP is
shown for clarity. (B) We also show the expression of the suture marker and craniosynostosis gene, Twist1 by in situ hybridization (upper panel) with an adjacent ALP-stained
section (middle panel) and their superimposed image (lower panel). Note that Jagged1 and Twist1 are both expressed in the prospective coronal suture (arrows), as well in an
ectocranial cell layer (EL). CS, prospective coronal suture; EL, ectocranial layer; FB, prospective frontal bone; PB, prospective parietal bone. Scale bars: 50 μm.
Fig. 2. Conditional inactivation of Jagged1 in mesoderm and not in neural crest results in craniosynostosis and defects in the boundary between the coronal suture and prospective
frontal and parietal bones. (A–C) The R26R allele served as an indicator of either Mesp1-Cre, Dermo1-Cre or Wnt1-Cre activation in E14.5 embryos. Staining for ALP (below lacZ-
stained sections) revealed osteogenic cells and the coronal suture. Punctate lacZ staining is apparent in the prospective coronal suture, parietal bone, and dermis ofMesp1-Cre;R26R
and Dermo1-Cre;R26R embryos. Wnt1-Cre resulted in robust lacZ staining for the frontal bone (FB) and meninges (M). (D–G) Immunostains for Jagged1 to assess the inﬂuence of
Mesp1-Cre, Dermo1-Cre or Wnt1-Cre on Jagged1 protein. Note Jagged1 expression in ectocranial layer (above ALP) and in prospective sutural cells (arrow). In Mesp1-Cre mutant,
Jagged1 is selectively lost in sutural cells. In the Dermo1-Cremutant, Jagged1 is reduced in both the ectocranial layer and suture. In theWnt1-Cremutant, Jagged1 is unaffected. (H–L)
We produced mice with the ﬂoxed Jagged1 allele in combination with the indicated Cre lines.Mesp1-Cre;Jagged1cko/cko embryos died around E13.5-E15.5; consequently we examined
the morphology of the developing coronal suture at E14.5 by means of whole mount ALP staining (H, I).Mesp1-Cre;Jagged1cko/cko mutants exhibited a narrowing of the prospective
coronal suture (CS) (I, arrow). We examined the skulls of Dermo1-Cre;Jagged1cko/cko andWnt1-Cre;Jagged1cko/cko mice at P21 by staining with Alizarin Red S (J–L). Note that coronal
synostosis in the Dermo1-Cre;Jagged1cko/cko mutant (K, arrows). Sutures of Wnt1-Cre;Jagged1cko/cko mice were normal, but an ossiﬁcation defect was apparent in the frontal bone
(L, arrow). (M, N) To assess the boundary between the coronal suture and adjacent bone territories we produced mice with the R26R allele withMesp1-Cre;Jagged1cko/cko (N). Note
substantial numbers of lacZ positive cells in the frontal bone territories (N, arrowheads). Heads were sectioned as in Fig. 1. CS, coronal suture; FB, frontal bone; M, meninges; PB,
parietal bone; SS, sagittal suture. Scale bars: 50 μm in A–G, M, N; 500 μm in H, I; 1 mm in J–L.
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Jagged1 is required in mesoderm and not in neural crest for the
development of the coronal suture
We examined the expression of Jagged1 at E14.5, when the
boundary between osteogenic and non-osteogenic cells becomes
evident (Merrill et al., 2006; Ting et al., 2009). Immunostaining with a
Jagged1-speciﬁc antibody revealed Jagged1 protein in a speciﬁc group
of cells within the prospective coronal suture, which is derived from
mesoderm (Yoshida et al., 2008) (Fig. 1A, arrow). These cells are
located below a line extending outward from the parietal bone and
above a line extending from the frontal bone. From previous work,
most or all of the cells in this area contribute to the coronal suture
(Yoshida et al., 2008). Whether the Jagged1 positive cells are a subset
of cells in the suture or all of the cells is not clear. We note that cells
medial to the frontal bone osteogenic front, which are derived from
neural crest, do not contribute to the suture but instead appear to
form bone as the leading edge extends (our unpublished observa-
tions). Cells medial to the parietal bone are derived from mesoderm
and thus cannot be distinguished from sutural cells with mesoderm
Cres. However, by analogy with the corresponding cells adjacent toFig. 3. Inactivation of Jagged1 in mesoderm causes an expansion of Notch2 and Hes1 expressi
inﬂuence of lineage-speciﬁc inactivation of Jagged1 on the distribution of the Jagged1 recep
genotypes were sectioned as shown in Fig. 1 and subjected to immunostaining. Alternate sect
Notch2 was expressed in the prospective bone territories and was excluded from the coronal
knockouts of Jagged1, Notch2 and Hes1 expression expanded into the prospective suture (
knockout (C). CS, coronal suture; FB, frontal bone; PB, parietal bone. Scale bars: 50 μm.the frontal bone, we believe these cells are ultimately incorporated
into the parietal bone.
Jagged1 staining was also apparent in a layer of cells outside the
prospective bone layer. This layer, which is also derived from
mesoderm, is of interest because osteogenic precursor cells migrate
within it (Ting et al., 2009). There was little or no expression in the
neural crest-derived frontal bone, indicating that Twist1 expression
overlapped signiﬁcantly with that of Jagged1, both in the suture and in
the layer of cells outside the prospective bone (Fig. 1B).
This pattern of Jagged1 expression suggested that it might function
in the speciﬁcation of sutural cells or in the development of osteogenic
precursor cells. We used a genetic approach to examine these
possibilities. Mice homozygous for a conventional Jagged1 knockout
allele die at E10.5, precluding an examination of Jagged1 function in
the development of the skull vault and sutures (Xue et al., 1999).
Jagged1+/− mice have no detectible defects in skull vault develop-
ment (Xue et al., 1999; our unpublished observations). We therefore
used a conditional Jagged1 allele (Brooker et al., 2006) to address the
function of Jagged1 in the skull.
We used two different Cre alleles, Mesp1-Cre (Saga et al., 1999),
and Dermo1-Cre (Yu et al., 2003), to assess Jagged1 function in
mesoderm-derived tissues of the developing coronal suture (Fig. 2).on domains in the prospective coronal suture. We used immunostaining to examine the
tor, Notch2 (A-D) and the Notch target, Hes1 (E, F). Embryos at E14.5 of the indicated
ions were stained for ALP to reveal prospective bone. Note that in wildtype embryos (A),
suture. Hes1 was expressed similarly (E). In bothMesp1-Cre- and Dermo1-Cre-mediated
B, D, F). No change in Notch2 expression was evident in a Wnt1-Cre-mediated Jagged1
262 H.-Y. Yen et al. / Developmental Biology 347 (2010) 258–270We used Wnt1-Cre to assess function in the adjacent neural crest-
derived cells of frontal bone and dura. The Dermo1-Cre allele was
generated by knocking the Cre gene into the Twist2 locus. Because
Twist2 is related to Twist1, we were concerned that the Dermo1-Cre
allele might interact with Twist1 or Jagged1 in coronal suture
development. Three sets of ﬁndings argue against these possibilities.
First, loss of Dermo1 function does not result in a defect in coronal
suture development (Bialek et al., 2004). Second, a test cross of
Dermo1-Cre with Twist1 mutants revealed that mice with the
genotypeDermo1-Cre;Twist1+/− did not exhibit amore severe coronal
suture defect than Twist1+/− mice in a comparison of 3 littermate
pairs (data not shown). Third, mice with the genotype Dermo1-Cre;Fig. 4. Interactions between Jagged1 and P-Erk1/2, P-Smad1/5/8, Wnt-β-catenin, and ephrinA
inactivation of Jagged1 on the distribution of P-Erk1/2 (A, B), P-Smad1/5/8 (C, D), β-catenin (E,
EphA4 function on Jagged1 expression.Wildtype andmutant embryos at E14.5 were prepared a
Jagged1, the antibodieswere visualizedwith DAB (brown color) and sectionswere counterstain
Rhodamine Red-X-conjugated secondary antibody (red color). Nuclei were stainedwith DAPI (
transformed to yellow tomake it more visible. ALP stains of adjacent sections are shown below
areas in the upper panels. Note that inwildtype embryos, P-Erk1/2, P-Smad1/5/8were expresse
in the suture but was largely cytoplasmic. In Dermo1-Cre;Jagged1cko/ckomutants, P-Erk1/2 expre
Smad1/5/8 expression expanded into the sutural mesenchyme, similar to Notch2 and Hes1 exp
not change in the EphA4−/−mutant coronal suture (I, J). CS, coronal suture; FB, frontal bone; PJagged1cko/+ (n = 10), like Jagged1+/− mice did not exhibit a coronal
suture defect (data not shown). These results suggest that Dermo1
does not interact with either Twist1 or Jagged1 in the coronal suture
and thus support the use of Dermo1-Cre for investigating Jagged1
function in the coronal suture.
To test the ability of Mesp1-Cre and Dermo1-Cre to cause
recombination in the mesoderm-derived portion of the coronal
suture, we crossed mice carrying each of these alleles with mice
carrying R26R. Staining of sections through the coronal suture for lacZ
revealed that both Dermo1-Cre andMesp1-Cre drove recombination in
areas of the developing suture known to be derived from mesoderm,
including cells of the suture itself, the parietal bone, and the-EphA pathways in the coronal suture. We examined the inﬂuence of mesoderm-speciﬁc
F) and ephrinA2 (G, H) in the coronal suture. (I, J)We also assessed the inﬂuence of loss of
s in Fig. 1 and sectionswere stainedwith indicated antibodies. For P-Erk1/2, ephrinA2 and
edwith hematoxylin. For P-Smad1/5/8 andβ-catenin, the antibodieswere visualizedwith
blue). In the case of β-catenin, the pink color of DAPI, β-catenin double positive nuclei was
images of immunostains. The lower panels in A, B and E, F are enlargements of the boxed
d in prospective bone and osteogenic fronts but not in the suture.β-cateninwas expressed
ssion was coincident with ALP expression in the frontal and parietal bones. In contrast, P-
ression (Fig. 3D, F), and ephrinA2 expressionwas unaltered (G, H). Jagged1 expression did
B, parietal bone. Scale bars: 50 μm.
Fig. 5. Increased severity of craniosynostosis in Twist1-Jagged1 combination mutants. To test for a genetic interaction between Twist1 and Jagged1, we compared skull morphologies
of individual mutants with those of compound heterozygotes. Pups of the indicated genotypes were taken at P21 and the skulls were stained with Alizarin Red S. (A–D) Note bilateral
coronal synostosis in Twist1+/−;Jagged1+/− skull (D, arrows) compared with partial unilateral synostosis in Twist1+/− skull (C, arrow) and normal suture morphology in wildtype
and Jagged1+/− skulls (A, B). The lambdoid (LS), squamosal (SQ) and occipitointerparietal (OIP) sutures also exhibited more severe synostosis in the compound heterozygotes
compared with individual mutants (D–H). CS, coronal suture; FB, frontal bone; IF, interfrontal suture; LS, lambdoid suture; OIP, occipitointerparietal suture; PB, parietal bone; SQ,
squamosal suture; SS, sagittal suture. Scale bars: 1 mm. See Tables 1 and 2.
263H.-Y. Yen et al. / Developmental Biology 347 (2010) 258–270ectocranial layer (Fig. 2A, B). Staining was punctate, indicating that
recombination did not occur in all mesoderm-derived cells. Wnt1-Cre,
as expected, drove recombination in cells of the frontal bone and
underlying dura (Fig. 2C).
We next produced mice with the genotypes Mesp1-Cre;
Jagged1cko/cko, Dermo1-Cre;Jagged1cko/cko, and Wnt1-Cre;Jagged1cko/cko,
and used immunostaining with a Jagged1 antibody to assess the
expression of Jagged1 in mutant sutures at E14.5. As is evident in
Fig. 2, D-G, Mesp1-Cre selectively reduced Jagged1 expression in
sutural cells (Fig. 2E, arrowhead), and had a smaller effect onTable 1
Penetrance of craniosynostosis in Jagged1+/−; Twist1+/− and Twist1+/−;Jagged1+/− mice.a
Genotype n Coronal
L+R** (%)
Squamosal
L+R (%)
Wildtype 21 0 0
Jagged1+/− 14 0 0
Twist1+/− 18 44 28
Twist1+/−;Jagged1+/− 22 77 100
a The percentage of postnatal day 21 mice with suture fusion phenotypes was examined. T
coronal, right coronal, left squamosal, right squamosal, left lambdoid, right lambdoid, occ
alizarin red S-stained skulls.expression in cells of the ectocranial layer. Dermo1-Cre caused loss
of Jagged1 expression in both sutural and ectocranial cells (Fig. 2F).
Wnt1-Cre had no discernible effect on Jagged1 expression at either
location, conﬁrming that in the area of the coronal suture, Jagged1
was expressed selectively in mesoderm-derived cells (Fig. 2G).
We did not obtain any pups with the genotype Mesp1-Cre;
Jaggedcko/cko (of 90 examined), suggesting that homozygous inactiva-
tion of Jagged1 in mesoderm causes lethality during embryogenesis.
We examinedMesp1-Cre;Jagged1cko/cko embryos at E14.5 for evidence
of craniosynostosis. In both sections and whole mounts, staining forLambdoid
L+R (%)
OIP (%) Interfrontal (%) Penetrance in eight
sutures (%)
0 0 0 0
0 0 0 0
56 72 0 94
95 100 32 100
he synostosis phenotypes of ﬁve different sutures (totally eight sutures), including left
ipitointerparietal (OIP) and interfrontal suture, were examined under microscope on
Table 2
Craniosynostosis index (CI) of Jagged1+/−; Twist1+/− and Twist1+/−;Jagged1+/− mice.a
Genotype n Coronal
L+Rb
Squamosal
L+R
Lambdoid
L+R
OIP Interfrontal Sum score of
eight sutures
Wildtype 21 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0
Jagged1+/− 14 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0
Twist1+/− 18 0.6±0.8§ 0.8±1.3§ 1.7±1.8§ 0.7±0.5§ 0.0±0.0 3.8±2.3§§
Twist1+/−;Jagged1+/− 22 1.5±1.2§ 3.5±1.6§ 3.5±1.8§ 1.2±0.5§ 0.4±0.7§ 10.1±2.6§§
a The Craniosynostosis index (CI) is a scoring method adopted from Oram and Gridley, 2005. Eight sutures as indicated in Table 1 were scored for each skull. The degree of fusion
was assessed microscopically and scored (0: unfused; 1: b50% fused; 2: ≥50% fused and 3: 100% fused.) Scores for left and right sutures of the same type were added. For example,
the maximum score given to two coronal sutures in each skull is six. The mean score±SD for each type of sutures were calculated separately. The sum score of the eight sutures
represents the severity of craniosynostosis in each genotype. Pairwise comparisons among four genotypes were analyzed by two-tailed Student's t-test and signiﬁcant differences
are marked with (§) for Pb0.05 or (§§) for Pb0.000001.
b L+R: Left+Right sutures.
Table 3
Jagged1is required in the mesoderm for its interaction with Twist1 in the coronal
suture.a
Genotype n CI
Mesp1-Cre 15 0.1±0.3
Mesp1-Cre;Jagged1cko/+ 12 0.0±0.0
Mesp1-Cre;Twist1+/− 10 2.0±1.9
Mesp1-Cre;Jagged1cko/+;Twist1+/− 14 4.0±1.8
Wnt1-Cre 19 0.0±0.0
Wnt1-Cre;Jagged1cko/+ 16 0.0±0.0
Wnt1-Cre;Twist1+/− 13 1.4±1.7
Wnt1-Cre;Jagged1cko/+;Twist1+/− 16 2.1±1.5
a Skulls were collected at postnatal day 21 and stained with Alizarin Red S. The
Craniosynostosis index (CI) was calculated as in Table 2. All pairwise comparisons
(two-tailed Student's t-test) were signiﬁcantly different (Pb0.05), except for the
following: (1) Mesp1-Cre vs. Mesp1-Cre;Jagged1cko/+, (2) Wnt1-Cre vs. Wnt1-Cre;
Jagged1cko/+, and (3) Wnt1-Cre;Twist1+/− vs. Wnt1-Cre;Jagged1cko/+;Twist1+/−.
(PN0.1).
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narrowing of the prospective coronal suture, consistent with early
craniosynostosis (Fig. 2H, I, arrows) (Ting et al., 2009). Dermo1-Cre;
Jagged1cko/cko mutants were viable. Alizarin Red stains of P21 mutant
skulls revealed synostosis of the coronal sutures with a penetrance of
86% (n=14) (Fig. 2J, K).Micewith the genotypeWnt1-Cre;Jagged1cko/cko
were viable at least through P21. Their skulls showed no evidence of
synostosis of the coronal suture (Fig. 2L). However, anossiﬁcationdefect
was apparent in the frontal bone (Fig. 2L, arrow). The developmental
mechanism underlying this defect is not clear; one reasonable
explanation is that Jagged1 is expressed in a subset of neural crest
that contribute to the medial portion of the frontal bone, and that
inactivation of Jagged1 in these cells results in the defect.
Our previous ﬁndings showed that the boundary between
osteogenic and non-osteogenic cells in the coronal suture is
deﬁcient in craniosynostosis (Merrill et al., 2006; Ting et al.,
2009). Together with the well-documented role of Notch signaling
in boundary formation, these ﬁndings prompted us to test for
boundary defects within the coronal sutures of Jagged1 conditional
mutants. The osteogenic–non-osteogenic boundary coincides with
the neural crest-mesoderm boundary in the coronal suture. To
examine the osteogenic–non-osteogenic boundary, we crossed R26R
into Mesp1-Cre;Jagged1cko/cko mice and examined the distribution of
lacZ-expressing cells in the coronal suture. As is evident in Fig. 2N,
lacZ positive cells crossed from the mesoderm compartment to the
neural crest compartment in substantial numbers (arrowheads).
Jagged1 is thus required in the mesoderm to maintain the integrity
of the boundary between osteogenic and non-osteogenic cells in the
coronal suture.
NOTCH2 is mutated in some cases of Alagille syndrome (McDaniell
et al, 2006). It is also known to function cooperatively with Jagged1 in
the development of bile ducts (Lozier et al., 2008) and lens ﬁber cells
(Saravanamuthu et al., 2009), and can be negatively regulated by
Jagged1 (Yuan et al., 2006). This potential functional relationship
between Jagged1 and Notch2 prompted us to assess the inﬂuence of
Jagged1 on the expression of Notch2 in developing coronal sutures.
In wild type embryos at E14.5, Notch2 was expressed in ALP-
positive cells of the prospective frontal and parietal bones and was
excluded from the coronal suture (Fig. 3A). InMesp1-Cre;Jagged1cko/cko
and Dermo1-Cre;Jagged1cko/cko mutants, the domain of Notch2 expres-
sion expanded into the suture (Fig. 3B, D). This expansiondid not occur
inWnt1-Cre;Jagged1cko/ckomutants (Fig. 3C). These results suggest that
Jagged1 functions in mesoderm to exclude Notch2 expression or
Notch2-expressing cells from the coronal suture.
We next examined the expression of Hes1, a downstream effector
of Notch signaling (Jarriault et al., 1995), as an indicator of Notch
signaling activity. Hes1 was not expressed in sutural mesenchyme of
wild type mice, but was readily detectible in mutant sutures (Fig. 3E,
F), suggesting that inactivation of Jagged1 resulted not only in an
expansion of the Notch2 expression domain but also in an increase in
Notch signaling in the sutural mesenchyme. These data suggest that
loss of Jagged1 function results in an activation of Notch signaling inthe suture by a mechanism that involves either an increased
expression of the Notch2 protein in sutural cells or a movement of
Notch2-expressing cells into the suture.Interactions between Jagged1 and P-Erk1/2, P-Smad1/5/8, Wnt-β-
catenin, and ephrinA-EphA pathways in the coronal suture
We askedwhether loss of Jagged1 function inﬂuenced the activity of
the RTK, Bmp, and Wnt/β-catenin pathways in the developing suture.
Each is known to function during osteogenic differentiation and has
been implicated in craniosynostosis (Morriss-Kay and Wilkie, 2005).
Moreover, in previous work we noted a reduction in RTK signaling, as
assessed by P-Erk1/2, in EphA4mutants, which exhibit craniosynostosis
and defects in the osteogenic–non-osteogenic boundary (Ting et al.,
2009). Consistentwith our previous results, in control embryos, P-Erk1/
2 was expressed in cells of prospective bone, osteogenic fronts, and an
ectocranial cell layer, but not in the suture. In Dermo1-Cre;Jagged1cko/cko
mutants, P-Erk1/2 expression expanded, coincident with the expanded
ALP expression at the leading edges of the frontal and parietal bones
(Fig. 4A, B). The expression of ephrinA2 in the ectocranial layer was
unaffected, suggesting that loss of Jagged1 function inmesodermdidnot
affect ephrinA2 signaling at the ligand level (Fig. 4G, H).
The distribution of P-Smad1/5/8 expressing cells was altered in
Dermo1-Cre;Jagged1cko/cko mutants in a manner similar to the changes
we described previously in Twist1-EphA4 mutants (Ting et al., 2009).
Whereas in wild type sutures, P-Smad1/5/8 positive cells were
concentrated in the osteogenic fronts, in mutants, they were
distributed throughout the suture (Fig. 4C, D).
The expression of β-catenin was also changed in Dermo1-Cre;
Jagged1cko/cko mutant sutures compared with controls (Fig. 4E, F). In
control embryos, β-catenin was expressed throughout the suture, and
was distributed largely in the cytoplasm of sutural cells (Fig. 4E). In
mutants, there was a substantial increase in the overall level of β-
Fig. 6. Inﬂuence of Twist1 and Jagged1 on Notch signaling in the prospective coronal suture. We assessed the inﬂuence of Twist1 and Jagged1 on the expression of Notch2 and Hes1 in a developmental series of embryos. Sections of E12.5 (A–H)
and E13.5 (I–T) embryos of the indicated genotypes were prepared as in Fig. 1 and stained with antibodies against Jagged1 (A–D, I–L), Notch2 (E–H, M–P), and Hes1 (Q–T). At E13.5, Jagged1 is expressed in two layers. The lower of these is
reduced preferentially in Twist1+/− and Twist1+/−;Jagged1+/−mutants (K, L, arrowheads) . This layer gives rise to the coronal suture (see Fig. 7A–D). Alternate sections were stained for ALP. A superimposition of the Jagged1 immunostaining
and ALP, as well as a schematic diagram, is shown below the E13.5 sections for clarity (I-L). Note expansion of Notch2 into the prospective suture in both Twist1+/− and Twist1+/−;Jagged1+/−mutants at E12.5 (G, H, arrows) and E13.5 (O, P,
arrows). Also note expansion of Hes1, indicating an increase in Notch signaling in the suture (S, T, arrows). CS, coronal suture; FB, frontal bone; PB, parietal bone. Scale bars: 50 μm.
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266 H.-Y. Yen et al. / Developmental Biology 347 (2010) 258–270catenin staining (Fig. 4F). Moreover, the proportion of stained nuclei
increased sharply in the area of the suture.
Together, these results suggest that Jagged1 inﬂuences RTK, Bmp,
and Wnt/β-catenin signaling, but not ephrinA-EphA signaling, in the
coronal suture. Finally, to determine whether ephrinA-EphA signaling
inﬂuenced Jagged1 activity, we examined Jagged1 expression in EphA4
mutants. As is evident in Fig 4I, J, there was no change in Jagged1
expression, either in the prospective suture or in the ectocranial
mesenchyme. These results suggest that there is no discernible
interaction between Jagged1 and ephrinA-EphA signaling in the coronal
suture. Thus, in aggregate, our results suggest that the Notch and
ephrinA-EphA pathways function in parallel, downstream of Twist1.
A genetic interaction between Jagged1 and Twist1
The overlap in Twist1 and Jagged1 expression in the coronal suture
(Fig. 1), together with the similarity in Jagged1 and Twist1 mutant
phenotypes suggested that Twist1 and Jagged1 might interact
genetically. As a ﬁrst test of this possibility, we asked whether
heterozygous loss of Jagged1 function exacerbated the synostosis
defect in Twist1mutant mice. Twist1−/−mice die at E11.5, Jagged1−/−
mice at E10.5. Therefore we focused our analysis on compound
heterozygotes, which are viable. We crossed Twist1+/− and Jagged1+/−
conventional mutant mice and examined the coronal sutures in
compound mutant offspring (Fig. 5). Coronal synostosis in the Twist1
substrain used in this series of experiments had a penetrance of 44%,
lower than that of Twist1mutant strains examined previously (Merrill
et al., 1986; Ting et al., 2009). At P21, Twist1+/−;Jagged1+/mice
exhibited a substantial increase in the penetrance of synostosis of the
coronal suture in comparison to Twist1+/− mice. Increases in
penetrance were also apparent in the squamosal, lambdoid, occipi-
tointerparietal (OIP), and interfrontal sutures (Table 1).
We used a quantitativemeasure of synostosis, the craniosynostosis
index (CI) (Oram and Gridley, 2005) to assess the severity of the
craniosynostosis phenotype (Table 2). The CI includes the coronal,
lambdoid, squamosal, OIP and interfrontal sutures. The CI for each
individual suture was elevated signiﬁcantly in Twist1+/−;Jagged1+/−
mutants compared with other genotypes. Whereas the sum score was
3.8±2.3 for Twist1+/− mice at P21, it was 10.1±2.6 for Twist1+/−;
Jagged1+/− compound heterozygous mutants. These results are
consistent with a strong genetic interaction between Twist1 and
Jagged1 in the developing skull vault.
We next used the conditional Jagged1 allele, together with Wnt1-
Cre or Mesp1-Cre, and the conventional Twist1 allele, to compare the
strength of the interaction between Jagged1 and Twist1 in neural crest
and mesoderm. From data presented in Table 3, mice with the
genotype Mesp1-Cre;Jagged1cko/+;Twist1+/− exhibited a signiﬁcantly
greater craniosynostosis index (4.0±1.8) than mice with the Twist1
heterozygous knockout alone (2.0±1.9). In contrast, whenWnt1-Cre
was used in place ofMesp1-Cre, there was no signiﬁcant difference in
the craniosynostosis index. These data suggest that Jagged1 is required
in mesoderm for its interaction with Twist1.
To investigate the basis of the interaction between Twist1 and
Jagged1, we assessed the inﬂuence of reduced dosage of both genes
individually and together on the expressiondomains of Jagged1,Notch2
and Hes1 (Figs. 6 and 7) at several stages of development, including
E12.5 and E13.5 prior to any boundary defects in Jagged1 or Twist1
mutant embryos, as well as at E14.5 when such defects are evident.Fig. 7. Twist1 and Jagged1 function together to maintain a boundary between the coronal sutur
Cre;R26R together with the allelic combinations Jagged1+/−, Twist1+/− and Twist1+/−;Jagg
combination with Jagged1 immunostaining in such mutants at E14.5 (A–D, upper panels). We
panels in A–D show a superimposition of the two images above. Note that Jagged1 expression i
D). Also note lacZ positive cells crossing into sutural mesenchyme (C, D, arrowheads). (E–L) Th
K, L arrows with I, J, arrowheads) into sutural mesenchyme of Twist1+/− and Twist1+/−;Jagge
(M) Twenty serial sections (forty coronal sutures) from a similar level were selected from each
the coronal mid-suture mesenchyme (as indicated by arrowheads in C, D) was counted. ErroAt E12.5, Jagged1 protein was located in the frontal and parietal
bone territories, whichwere identiﬁed by the expression of ALP. In the
parietal bone territory, Jagged1 expression extended beyond the ALP
domain into an area of prospective osteogenic tissue and further into
the coronal suture (Fig. 6A). Notch2 expression overlapped with ALP
activity and was detectable but reduced in the prospective coronal
suture (Fig. 6E).
In Jagged1+/− embryos, Jagged1 expression was downregulated
slightly (Fig. 6B), as expected. In Twist1+/− mutant embryos at this
stage Jagged1 expression changed little if at all (Fig. 6C), but the
Notch2 expression domain expanded into the sutural mesenchyme
(Fig. 6G). This suggests that Twist1 is required to exclude Notch2 from
the prospective suture. Combination Twist1+/−;Jagged1+/− mutants
exhibited a reduction in Jagged1 expression and an expansion of
Notch2 expression similar to that of Twist1+/− embryos (Fig. 6D, H).
This expansion of Notch2 at E12.5 presages changes in ALP activity
that accompany craniosynostosis.
In control embryos at E13.5, Jagged1 expression in the parietal
bone territory resolved into two bands of cells ﬂanking the
prospective parietal bone (Fig. 6I, arrows). The upper band was
continuous across the coronal suture ectocranial to the developing
frontal bone. Notch2was expressed in the prospective bone territories
endocranial to the outer band of Jagged1 expression, and was
excluded from the prospective coronal suture (Fig. 6M). Hes1 was
expressed at low levels in both the frontal and parietal bone territories
and was also excluded from the prospective coronal suture (Fig. 6Q).
These patternswere virtually identical in Jagged1+/−mutants (Fig. 6J,
N, R), butwere signiﬁcantly different in Twist1+/− and Twist1+/−;Jagged1
+/−mutants. Jagged1 expression in the endocranial bandwas reduced in
Twist1+/−mutants andwas largely lost in Twist1+/−;Jagged1+/−mutants
(Fig. 6K, L). In Twist1+/− and Twist1+/−;Jagged1+/− mutants, both
Notch2 and Hes1 expanded into the coronal suture (Fig. 6O, P, S, T).
Similarly, at E14.5, in wildtype embryos, Jagged1 continued to be
expressed in sutural cells (Fig 7A, arrow) and in the ectocranial layer.
Expression in sutural cells was selectively lost in Twist1 mutants.
Notch2 and Hes1 continued to be expressed in the osteogenic layer
(Fig. 7E, I), and in Twist1+/− and Twist1+/−;Jagged1+/− combination
mutants, Notch2 and Hes1 expanded into the Jagged1 domain in the
midsutural mesenchyme (Fig. 7G, H, K, L). We note ﬁnally that Twist1
expression was not inﬂuenced by Jagged1 gene dosage (data not
shown).Jagged1 and Twist1 cooperatively control the boundary between
osteogenic and sutural cells in the coronal suture
We also assessed the status of the neural crest-mesoderm
boundary in Twist1+/−;Jagged1+/− mutants. We used Wnt1-Cre;
R26R to mark the neural crest territory, which coincides with the
osteogenic cells of the frontal bone (Ting et al., 2009). As is evident in
Fig. 7C and D, lacZ positive cells crossed into the Jagged1 sutural
expression domain in both Twist1+/− and Twist1+/−;Jagged1+/−
mutants. The total number of boundary-crossing LacZ-positive cells,
summed over the whole length of the coronal suture, increased
signiﬁcantly in the Twist1+/−;Jagged1+/− mutants compared with
Twist1+/− mutants (Fig 7M). The average number of boundary-
crossing cells per section was approximately the same (not shown).
Thus the genetic combination of Twist1 and Jagged1 resulted in ane and adjacent osteogenic territories. (A–D)We produced mice with the genotypeWnt1-
ed1+/−. We examined the distribution of lacZ positive (neural crest-derived) cells in
also examined the expression of ALP by histochemistry (A–D, middle panels). The lower
s selectively reduced in the suturalmesenchyme inmutants (compare A, arrow, with B, C,
e expansion of Notch2 (compare G, H, arrows with E, F, arrowheads) and Hes1 (compare
d1+/−mutants. CS, coronal suture; FB, frontal bone; PB, parietal bone. Scale bars: 50 μm.
of two embryos of the indicated genotypes and the total number of lacZ-positive cells in
r bars represent one standard deviation based on two biological replicates.
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of the coronal suture over which boundary-crossing events occurred.
Discussion
We sought to test the role of the Notch pathway in craniosy-
nostosis and in the formation of a compartment boundary in the
coronal suture. Our focus was the Notch ligand, Jagged1, because of
its function in boundary formation and Alagille syndrome, which has
craniosynostosis as a feature (Kamath et al., 2002). Here, by means
of conditional targeting, we show that inactivation of Jagged1 in the
coronal suture results in craniosynostosis. It also results in changes
in the identity of sutural cells as early as E12.5 prior to overt
osteogenic differentiation, as well as defects in the boundary
between osteogenic and non-osteogenic cells in the coronal suture.
Surprisingly these changes are associated with increased Notch2
expression and Notch signaling activity in the sutural mesenchyme.
Finally, we found that Twist1 controls Jagged1 and Notch2
expression in the prospective coronal suture and Twist1 and Jagged1
exhibit a strong genetic interaction. Thus in addition to its role in the
regulation of ephrin-Eph signaling in the coronal suture (Merrill et
al., 2006; Ting et al., 2009), Twist1 also regulates the Notch pathway,
linking Alagille and Saethre–Chozen syndromes at the pathophysi-
ological level.
It is becoming increasingly clear that at least some forms of
craniosynostosis have their beginnings during embryonic develop-
ment. Our earlier work showed that heterozygous loss of Twist1
function causes defects in the boundary between osteogenic and non-
osteogenic cells in the coronal suture as early as E14.5 (Merrill et al.,
2006). Recently, we demonstrated that these changes are mediated in
part by ephrin-Eph signaling (Ting et al., 2009). Mice carrying the
Apert Fgfr2S252W mutant allele exhibit osteogenic differentiation of
the sutural mesenchyme at E13.5 (Holmes et al., 2009). The present
study pushes back the detection of a change in sutural cells in a
craniosynostosis disorder to E12.5 with our ﬁnding of expansion of
the Notch2 expression domain into the prospective suture and a
corresponding increase in the activity of the Notch effector, Hes1. The
expansion of Notch2 presages changes in ALP activity that precedes
craniosynostosis. Notch2 is normally expressed in osteogenic cells of
the frontal and parietal bones. Increased Notch signaling can promote
osteogenic differentiation in MC3T3-E1 osteoblastic cells and primary
human bone marrow mesenchymal stem cells (hMSCs) (Nobta et al.,
2005; Tezuka et al., 2002). Also, Hes1 can serve as a coactivator for
Runx2 in rat ROS17/2.8 osteoblastic cells (McLarren et al., 2000) and
MC3T3-E1 cells (Suh et al., 2008). Therefore upregulation of Notch
signaling in the coronal sutures of Jagged1mutants is consistent with
the subsequent change in sutural cells to an osteogenic identity.
Conversely, exclusion of Notch activity from sutural cells may serve to
maintain such cells in a non-osteogenic state.
In addition to a potential role in controlling the speciﬁcation of
sutural cells, Jagged1may also be part of amechanism thatmaintains a
boundary between the osteogenic and non-osteogenic compartments
of the coronal suture. The expression of Jagged1 in the sutural
mesenchyme and not in the adjacent osteogenic territory supports
such as role. Moreover, our ﬁnding that mesoderm-derived cells cross
into the non-osteogenic territory of the coronal suture demonstrates
such role directly. Whether the change in sutural cell identity or the
mixing of osteogenic cells with sutural cells is the primary cause of the
inappropriate osteogenic differentiation of sutural cells remains
unclear. We did not detect cell mixing until E14.5, after the expansion
of Notch2 and Hes1 expression at E12.5 and E13.5. Ectopic ALP
expression was evident at E14.5. Given this temporal sequence, we
propose that an early event predisposes sutural cells to osteogenic
differentiation–but does not cause overt differentiation–and subse-
quent mixing of osteogenic cells with sutural cells provides a ﬁnal
stimulus for such differentiation.Work performed largely in Drosophila has shown that a major
function of compartment boundaries is to establish specialized border
cells between the two compartments (Blair, 2003; Irvine and
Rauskolb, 2001). These cells are sources of morphogens that inﬂuence
the fate of cells ﬂanking the boundary. The Notch pathway has a
prominent role in the development of such cells in several
developmental settings, including the dorsal–ventral boundary of
the wing imaginal disc (Irvine and Rauskolb, 2001; Micchelli et al.,
1997). In this tissue, Notch is ﬁrst expressed broadly on both sides of
the boundary. Subsequently, through the actions of the dorsally
expressed selector gene, Apterous, the Notch ligand Serrate is
stimulated dorsally, the Notch ligand Delta is repressed, and the
Fringe glycosyl transferase is induced dorsally. Fringe alters the
glycosylation of Notch in dorsal cells, making it more sensitive to Delta
but insensitive to Serrate. The end result is activation of Notch in a
narrow band of cells at the D/V boundary.
We suggest that in the coronal suture, the Notch pathway also
functions in the speciﬁcation of a group of border cells—sutural cells
crucial for the development of the suture. At E12.5, Notch2 is
expressed in the frontal and parietal territories and at a lower level
in the area of the prospective coronal suture (Fig. 6). This reduced
expression in the prospective suture requires Twist1. By E14.5, Notch2
expression and Notch pathway activity as assessed by Hes1
expression are excluded from the prospective suture. Jagged1
expression begins broadly, overlapping Notch2, but becomes localized
to two narrow bands of cells, one ectocranial to the prospective bone,
the other located at the boundary between the osteogenic compart-
ments of the frontal and parietal bones. This latter band of cells
exhibits reduced expression of Notch2 and Hes1. These cells, we
propose, serve as border cells. Loss of Twist1 or Jagged1 function
results in expansion of Notch2 and Hes1 into the area of these cells.
The result is an increase in cells expressing P-Smad1/5/8, nuclear β-
catenin, and P-Erk1/2, as well as a loss of integrity of the osteogenic–
non-osteogenic boundary.
Golson et al. (2009b) made the interesting observation that during
pancreas development, Jagged1 loss of function phenocopies an
increase in Notch signaling, consistent with our demonstration of an
inhibitory role for Jagged1. These authors suggest that the Notch
glycosyltransferase, Mfng, may ﬁgure in this process, by causing
Jagged1 to act as a competitive inhibitor of signaling mediated by the
Notch ligand, Dll1. In a survey of Notch ligands expressed in the
coronal suture, we found that Dll1 was expressed in a very limited
domain in the central portion of the suture, and that its expression did
not change in Jagged1 mutants (data not shown). Thus we believe
that a competition between Jagged1 and Dll1 is not likely to be part of
the mechanism by which Jagged1 inhibits Notch signaling in the
suture. The nature of this mechanism remains obscure.
We note that NOTCH2 is mutated in some cases of Alagille
syndrome (McDaniell et al., 2006). Affected individuals, similar to
Notch2 mutant mice, have a spectrum of defects that overlap with
those present in individuals with Jagged1 mutations. However, these
defects do not include craniosynostosis. Our results may provide an
explanation for this lack of craniosynostosis in individuals carrying
Notch2 mutation: that loss of Jagged1 function in mice results in an
increase in Notch signaling in the suture–and craniosynostosis–
predicts that gain of function rather than loss of function mutations in
NOTCH2 in humans would cause craniosynostosis. Thus far germline
gain of function mutations in NOTCH2 have not been reported.
Molecular epistasis experiments did not identify cross regulatory
interactions between Jagged1 and ephrinA-EphA signaling in the
coronal suture (Fig. 4). Thus Jagged1 is not likely to be upstream of the
ephrin-Eph or Fgf pathways. Whether Erk1/2 signaling controls
Jagged1 remains to be determined. We did detect an increase in
nuclear β-catenin-expressing cells in sutures of Dermo1-Cre;Jag-
ged1cko/cko mutants. Liu and colleagues showed that inactivation of
theWnt pathway inhibitor, Axin2, results in craniosynostosis, and that
Fig. 8. Schematic model of regulatory interactions during coronal suture development
and craniosynostosis. The present ﬁndings, together with our previous results on an
interaction between Twist1 and EphA4 (Ting et al., 2009), place Twist1 at the top of a
regulatory hierarchy, controlling two independent pathways, Jagged1/Notch and
ephrinA-EphA. Twist1 positively regulates Jagged1 in sutural mesenchyme. Jagged1
represses Notch2. Jagged1/Notch functions in the initial speciﬁcation of sutural cells
and in the boundary between the osteogenic and non-osteogenic compartments in the
coronal suture. Jagged1 is also required to exclude β-catenin, P-Smad1/5/8, and P-Erk1/
2 from sutural cells. Twist1 is required for the expression of EphA4 and ephrinA2 in the
ectocranial mesenchyme (Ting et al., 2009). EphrinA-EphA signaling, functioning
through the RTK pathway, controls the guidance of osteogenic cells along the
ectocranial mesenchyme to their destinations in the developing frontal and parietal
bones. A failure of this process results in mis-migration of osteogenic precursor cells
into the coronal suture. Heterozygous loss of Twist1 function results in downregulation
of both EphA4 and Jagged1 and consequent changes in osteogenic precursor migration
and the osteogenic–non-osteogenic boundary in the coronal suture. Genetic combina-
tions of EphA4−/− or Jagged1+/− with Twist1+/− exacerbate these defects, as expected.
Jagged1 and EphA4 do not inﬂuence each other's activity. Thus the Notch and ephrinA-
EphA pathways act in parallel downstream of Twist1.
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These ﬁndings, together with our demonstration that β-catenin is
upregulated in Jagged1mutant sutures raises the possibility that a key
function of Jagged1 is to exclude β-catenin/Wnt activity from sutural
cells and thus maintain such cells in a non-osteogenic state. We also
noted a change in the distribution of P-Smad1/5/8 expressing cells in
Jagged1mutants. This change was similar to a change in Twist1-EphA4
mutants that we described previously (Ting et al., 2009). In wildtype
sutures, P-Smad1/5/8 positive cells were concentrated in the
osteogenic fronts; in mutants, they were distributed throughout the
suture, consistent with sutural cells assuming an osteogenic identity.
Our present ﬁndings, taken together with our previous results on
an interaction between Twist1 and EphA4 (Ting et al., 2009), provide
an outline of regulatory interactions in coronal suture development
(Fig. 8). These results place Twist1 at the top of a regulatory hierarchy,
controlling two independent pathways, ephrin-Eph and Jagged1/
Notch. Ephrin-Eph functions in the guidance of osteogenic cells along
the ectocranial mesenchyme to their destinations in the developing
frontal and parietal bones. A failure of this process results in mis-
migration of osteogenic precursor cells into the coronal suture.
Jagged1/Notch functions in the initial speciﬁcation of sutural cells and
in the boundary between the osteogenic and non-osteogenic
compartments in the coronal suture. Jagged1 is also required to
exclude β-catenin from sutural cells. Heterozygous loss of Twist1
function results in downregulation of both EphA4 and Jagged1 and
consequent changes in osteogenic precursor migration and the
osteogenic–non-osteogenic boundary in the coronal suture. Genetic
combinations of EphA4−/− or Jagged1+/− with Twist1+/− exacerbate
these defects, as expected.
Our results show that in Twist1-Jagged1mutants, synostosis occurs
in the squamosal, lambdoid, occipitointerparietal, and interfrontal
sutures in addition to the coronal, implying that mechanisms similarto those we have identiﬁed in the coronal suture may operate in other
sutures. These sutures differ from the coronal in that the boundary
between non-osteogenic cells of the suture and osteogenic cells of the
adjacent bone is not coincident with known lineage boundaries. We
point out, however, that the absence of a lineage boundary does not
prove that developmental boundary does not exist. A lineage
restriction is a consequence of heritable gene regulatory mechanisms
operating in two compartments (Irvine and Rauskolb, 2001). If the
expression of cell–cell interaction genes crucial for boundary
formation is not regulated by heritable mechanisms, but instead by
local signaling, then a precise lineage boundary need not be present in
order for a developmental boundary to be established. Thus we
predict that a set ofmechanisms similar to thosewe have documented
in the coronal suture, involving ephrin-Eph and Notch signaling under
the control of Twist1, also functions in other sutures to establish and
maintain boundaries between osteogenic and non-osteogenic
compartments.
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